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Tumour metastasis refers to the spread of cancer cells from the 
initial site of primary tumor to a distant secondary location.    
Cancerous tumor usually possesses a very large number of cells 
with genetic mutations which motivate them to grow, proliferate, 
and then, invade the local surrounding tissues [1]. As the tumor 
grows larger, some of the cells are dislodged from the main     
tumor and carried away by the blood or lymphatic vessels. These 
"circulating tumor cells" or CTCs possess important information 
about the primary tumor from which they are detached [1-3]. In 
fact, the presence and quantity of CTCs in the cancer patients' 
blood stream have been known to correlate directly to the stage 
of cancer as well as the effectiveness of cancer therapies [4]. The 
ability to isolate and enrich a large number of intact CTCs for 
analysis and characterisation will be pivotal for deepening our 
understanding of the metastatic process [5]. However, the       
extremely low abundance of CTCs in the blood makes 
enumeration and characterisation a huge technical challenge [6]. 
As CTCs are closely related to the growth of primary tumor and 
development of metastasis, they have great potential values for 
early   cancer detection, prognosis evaluation, and cancer drug 
efficacy monitoring. In comparison with hematologic cells, CTCs 
cannot be easily studied because of their rarity (i.e., in the order 
of 1 to 10 per mL of whole blood). Recent studies have shown 
that CTCs are different from other hematologic cells in terms of 
their surface molecules expression (EpCAM) [7], size [8], density 
[9], stiffness [10], adhesion [11], and electrical properties . As 
their isolation is still a major challenge, very rare information is    
available regarding their nature and behaviour.  
A number of recent reports on their isolation and 
characterization have marked them as cells having 
proliferative  potential and hypothesized that these cells are 
not just carcinoma cells but cancer stem cells who have left 
their origin for metastasis under the instructions of 
unknown regulatory mechanisms and cascades. Successful 
characterization of CTCs will help oncologists to treat 
cancer in   better way which is a major health problem in 
the world. 
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